Medical Oncologist
Your report explained
Perineural invasion and other less common report findings
Perineural invasion means the pathologist saw cancer cells growing along a small nerve in the breast tissue. In breast cancer it is uncommon and, on its own, it rarely changes what is recommended. This page explains it and the other unusual lines you may find on your report, and separates the ones that matter from the ones recorded for completeness.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does perineural invasion mean on my report?
- Other less common lines, in plain language
- How uncommon findings are actually used
- Questions that get you a useful answer
- Why searching a single phrase misleads you
- What people assume about unusual report lines
- Common questions about uncommon report findings
The short answer
What does perineural invasion mean on my report?
Perineural invasion means the pathologist saw cancer cells growing along or around a small nerve in the breast tissue. In breast cancer it is an uncommon finding and, on its own, it rarely changes what is recommended for you.
Why it is reported at all
Nerves run through breast tissue like everything else, and cancer can grow along the sheath around them. In some other cancers this finding carries real weight in planning surgery and radiotherapy. In breast cancer it is recorded for completeness rather than because it drives a decision.
What it does not mean
It does not mean the cancer has reached your nerves in a way that will cause pain or weakness. It does not mean it has spread. It is a microscopic observation about a few millimetres of tissue that has already been removed from your body.
If this is the only unusual line on your report, it is reasonable to ask whether it changed anything at all in your plan.On your report
Other less common lines, in plain language
- Perineural invasion
- Cancer cells growing along the sheath around a small nerve. Uncommon in breast cancer and rarely decision-changing on its own.
- Skin or dermal involvement
- Cancer reaching the skin over the breast. This does affect staging and the plan, and your team will have discussed it with you.
- Nipple involvement, or Paget disease
- Cancer cells found in the nipple. It affects whether the nipple can be preserved during surgery.
- Chest wall involvement
- Cancer reaching the muscle or ribs beneath the breast. This raises the stage and usually changes the operation.
- Tumour infiltrating lymphocytes
- Immune cells found inside the tumour. Generally read as a favourable sign, particularly in triple negative cancers.
- Necrosis
- Dead tissue inside the tumour. It usually appears alongside faster growing cancers and is reported as part of the description.
Not sure whether this applies to you?
Ask an oncologistWhat it changes
How uncommon findings are actually used
The main lines on your report do the work. These add texture to the picture rather than redirecting it.
The core results decide the plan
Size, grade, node status, ER, PR and HER2 are what your treatment is built from. A tumour board works through those first and reads the remaining lines against them.
Some findings do change things
Skin, nipple and chest wall involvement genuinely affect staging and surgery. If one of those appears on your report, it will already have been part of the conversation.
Ask which of the findings on your report changed anything.Some are favourable
Not every unusual line is bad news. Immune cells found within the tumour are generally read as a good sign, and families often worry about a phrase that was actually reassuring.
Reporting varies between laboratories
Some pathologists record findings that others do not mention. A line missing from your report does not mean it was present and ignored, and a line present does not mean it was significant.
Worth asking
- Which lines drove the recommendation
- Which are recorded for completeness
- Would anything change without them
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Take this to your appointment
Questions that get you a useful answer
- Which findings on this report actually changed your recommendation
- Which lines are recorded for completeness and change nothing
- Is anything here unusual enough to warrant a second pathology opinion
- Would my treatment be different if this line were not present
- Can I have a copy of the full report rather than the summary
- What should I watch for at home, and what is not worth worrying about
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
Why searching a single phrase misleads you
Almost everyone reading this has typed one phrase from their report into a search box at night. The results that come back are usually about a different cancer, because these terms carry very different weight in different diseases.
The same words mean different things elsewhere
Perineural invasion is genuinely important in some head and neck and pancreatic cancers, and much of what is written about it online comes from that context. Reading it as though it applies to breast cancer produces an entirely wrong impression of your situation.
A report is read as a whole
Your oncologist does not weigh each line separately and add them up. They form a picture, and one uncommon line inside an otherwise ordinary report changes that picture very little. This is why the answer to your question is often a straightforward no.
What this page cannot tell you
It cannot tell you what your particular report means. It can tell you which questions produce a useful answer. Take the full report to your appointment, point at the line that worried you, and ask directly whether it changed anything. In most cases you will be told it did not, and that answer is worth hearing from the person treating you.
Commonly believed
What people assume about unusual report lines
An unusual finding means an unusual cancer.
Pathology reports describe everything the pathologist sees, and there is a long list of things that can be described. Most reports contain at least one line that sounds alarming and means very little for the plan.
Perineural invasion means I will get nerve pain.
It describes microscopic growth along a tiny nerve in tissue that has been removed. It does not predict pain, numbness or weakness. If you do have nerve symptoms after surgery, they usually have an entirely different and treatable cause.
My doctor did not mention it, so they missed it.
Doctors explain the findings that drove the decision, not every line on the page. It is entirely fair to ask about one specifically, and a good oncologist will be glad you read the report rather than filing it unopened.
I should change hospitals over a line like this.
A second opinion is always reasonable, and the useful version is one where another oncologist reads the same full report and the same slides. Changing centres on the strength of a phrase found online usually costs time and gains nothing.
Questions we are asked
Common questions about uncommon report findings
Is perineural invasion serious in breast cancer?
It is an uncommon finding that, on its own, rarely changes what is recommended in breast cancer. It carries much more weight in some other cancers, which is why searching the phrase produces frightening results that do not apply to you.
Does it mean I need chemotherapy?
Not by itself. Chemotherapy decisions rest on size, grade, node status and the receptor results, and sometimes on a gene test. Ask your oncologist directly whether this line featured in their recommendation.
Why does my report mention things my friend's did not?
Laboratories differ in what they record as standard. A longer report is not a worse report. It often just means the pathologist described more of what they saw, which is generally a good habit rather than a warning sign.
What are tumour infiltrating lymphocytes?
Immune cells found inside the tumour, showing your immune system recognised it. In triple negative breast cancer a high number is generally read as favourable. This is one line people worry about that is usually good news.
My report mentions necrosis. Is that bad?
It means some tissue inside the tumour had died, which tends to happen in faster growing cancers. It is part of the description rather than a separate problem, and the grade already captures how fast the cancer was growing.
Should I ask for a second pathology opinion?
It is reasonable where the diagnosis itself is unusual, where the receptor results look inconsistent with the appearance, or where a major decision turns on a borderline call. Ask the hospital in writing for the blocks and slides.
Does skin involvement change my stage?
Yes, it can, and it is one of the findings that genuinely matters. If it appears on your report it will have been part of the discussion about your operation and your radiotherapy rather than an incidental note.
Can I get the report explained without a full appointment?
Often yes. Many centres will go through a report over the phone or in a short review visit. It is a reasonable thing to ask for, particularly if a single line is keeping you awake and the next appointment is weeks away.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Breast cancer tests and their results
- National Cancer Institute — Perineural invasion
- Breast Cancer Now — Understanding your pathology results
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.